Hyaluronidase-trigger nanocarriers for targeted delivery of anti-liver cancer compound

Xu, Junxin; Chen, Siling; Yang, Jianmei; Nie, Zhengquan; He, Junnan; Zhao, Yong; Liu, Xiaoqing; Jin, Zhanpeng; Zhao, Yan

doi:10.1039/d3ra00693j

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Hyaluronidase-trigger nanocarriers for targeted delivery of anti-liver cancer compound

Abstract: HA/(MI)7-β-CD NCs exhibits HA receptor-mediated targeting and disassembly properties under HAase stimulation, which was utilized to trap, targeted deliver and controlled release of anti-liver cancer compound CSL.

Cited by 5 publications

References 55 publications

Synthesis of acid-activated reversible conversion supramolecular nanoplatform: application in drug delivery and anti-tumor activity

Synthesis of acid-activated reversible conversion supramolecular nanoplatform: application in drug delivery and anti-tumor activity

Enzyme-activated binary assembly for targeted, controlled delivery of anti-liver cancer compounds

Synthesis of stimuli-responsive copolymeric hydrogels for temperature, reduction and pH-controlled drug delivery

Contact Info

Product

Resources

About